U.S. Logistics Stock News

NasdaqGM:SOUN
NasdaqGM:SOUNSoftware

SoundHound AI Targets Autos And Enterprises With New Agentic+ AI Moves

SoundHound AI (NasdaqGM:SOUN) launched what it calls the first fully on-device, multimodal, multilingual Agentic+ AI platform for vehicles at NVIDIA GTC 2026. The company also entered a major partnership with Experis, becoming its exclusive conversational AI partner to roll out agentic AI solutions across enterprises, starting with healthcare. For investors tracking NasdaqGM:SOUN, these announcements arrive with the stock at $7.82 and a very large 3 year return of 294.9%. The share price...
NYSE:IOT
NYSE:IOTSoftware

Profit Turn, AI Safety Upgrades, and Share Shelf Might Change The Case For Investing In Samsara (IOT)

Earlier in March 2026, Samsara Inc. reported fourth-quarter revenue of US$444.3 million and full-year revenue of US$1.62 billion, turning a quarterly profit while nearly eliminating its annual net loss, and soon after filed a US$1.11 billion shelf registration for 34,842,934 Class A shares tied to employee stock programs. Around the same time, the company introduced new AI-driven coaching features for its fleet safety platform and secured a US$30.3 million arbitration award, changes that...
NYSE:S
NYSE:SSoftware

SentinelOne (S) Valuation Check As Shares Trade Near $14.49 And Narratives Flag Undervaluation

SentinelOne (S) is drawing investor attention as its shares trade around $14.49, with recent returns mixed over the past week, month, three months, year and year to date. See our latest analysis for SentinelOne. Recent trading hints at modest positive momentum, with a 1-day share price return of 1.40%, a 7-day share price return of 2.48% and a 30-day share price return of 4.47%, even as the 1-year total shareholder return sits at a 25.19% loss. If SentinelOne has you looking closer at AI...
NYSE:TXT
NYSE:TXTAerospace & Defense

The Bull Case For Textron (TXT) Could Change Following New Global Public-Safety Helicopter Orders – Learn Why

Textron’s Bell unit recently secured orders from South Africa’s National Transmission Company for seven Bell 407GX helicopters and from the Pasadena Police Department for two Bell 505 helicopters, all designated for utility and public safety missions. These contracts highlight how Textron is extending the reach of its helicopter portfolio into both international infrastructure work and specialized municipal law‑enforcement operations. Next, we’ll examine how these new helicopter orders,...
NYSE:LNC
NYSE:LNCInsurance

Lincoln National Expands Retirement Income Suite With New Estate Focused Annuities

Lincoln National (NYSE:LNC) has introduced two new fixed indexed annuities, Lincoln FlexAdvantage Income and Lincoln OptiBlend Income. The products include an Estate Lock Death Benefit aimed at legacy planning, along with upgraded digital tools for clients and financial professionals. This launch expands Lincoln National's retirement income offerings and adds new options for investors focused on income and estate planning. Lincoln National enters this product launch with a mixed recent...
NYSE:FCN
NYSE:FCNProfessional Services

A Look At FTI Consulting (FCN) Valuation As Recent Returns Show Mixed Momentum

FTI Consulting (FCN) has been drawing attention after recent share price moves, with the stock last closing at US$163.42. Investors are weighing this performance against its earnings profile and multi segment advisory business. See our latest analysis for FTI Consulting. The recent 1 day share price return of 0.93% and 7 day share price return of 0.65% sit against a 90 day share price return of 7.52% and a 1 year total shareholder return of 1.90%. This suggests momentum has cooled after...
NasdaqGS:HOOD
NasdaqGS:HOODCapital Markets

How Robinhood’s New Banking Push and Platinum Card Launch Will Impact Robinhood Markets (HOOD) Investors

In recent months, Robinhood Markets has expanded beyond trading by rapidly growing its new banking division past US$1.00 billion in deposits, rolling out a high-fee platinum credit card with extensive perks, and beginning a cautious launch of its Robinhood Social community feature in the US. These moves highlight Robinhood’s push to become a broader balance-focused financial platform with multiple recurring revenue streams spanning banking, cards, crypto, tokenized securities, and investing...
NYSE:AVTR
NYSE:AVTRLife Sciences

Eversept Ups Avantor Stake As Revival Program And Valuation Draw Focus

Eversept Partners has made a significant institutional investment in Avantor (NYSE:AVTR), increasing its ownership stake in the company. The move comes as Avantor presses ahead with its Revival program, which is aimed at responding to prolonged organic revenue declines and restructuring efforts. These ownership changes and internal initiatives are drawing fresh attention to Avantor's potential direction and risk profile. Avantor supplies products and services to the life sciences and...
NYSE:BK
NYSE:BKCapital Markets

Is It Too Late To Consider Bank of New York Mellon Corporation (BK) After 43% Rally?

Wondering if Bank of New York Mellon Corporation is still good value after a strong run, or if you might be paying up for past gains rather than future potential? BNY shares last closed at US$116.12, with returns of 0.6% over 7 days, a 1.4% decline over 30 days, a 0.8% decline year to date, and a 43.5% return over the past year. Recent attention on large financial institutions and their role in capital markets has kept BNY in focus, as investors weigh how its scale and business mix might...
NasdaqGM:PAHC
NasdaqGM:PAHCPharmaceuticals

Phibro Insider Moves Shift Class Structure As Stock Trades Near Highs

Director Jack Bendheim has sold a significant amount of NasdaqGM:PAHC stock under a pre arranged trading plan. BFI Co., LLC has converted 100,000 shares of Phibro Animal Health Class B Common Stock into Class A Common Stock. The transactions affect insider holdings, voting rights, and the mix between Class A and Class B shares in the company’s capital structure. Phibro Animal Health, listed on NasdaqGM:PAHC, focuses on animal health and nutrition products that support livestock producers...
NYSE:BAX
NYSE:BAXMedical Equipment

Baxter CFO Exit Tests Execution On Governance Reviews And Cost Discipline

Baxter International (NYSE:BAX) announced the departure of Chief Financial Officer Joel Grade, who will remain as an advisor through April 30, 2026. The Board appointed Anita Zielinski as interim CFO, effective immediately. The leadership change comes while Baxter continues its broader transition, including past governance issues, product safety reviews, and major divestitures. Baxter International operates across medical products and therapies, so stability in its finance function matters...
NYSE:WU
NYSE:WUDiversified Financial

Is It Time To Reconsider Western Union (WU) After Recent Share Price Weakness?

Wondering if Western Union at around US$9.25 is a potential bargain or a value trap? This article focuses squarely on what the current price might be implying. The stock has seen a 4.9% decline over the last 7 days and is down 3.6% over 30 days, while the 1 year return sits at a 4.4% decline and the 5 year return at a 44.9% decline. Year to date performance is close to flat at 0.2% and the 3 year return is 8.7%. Recent coverage has focused on Western Union's role as a global money transfer...
NYSE:HEI
NYSE:HEIAerospace & Defense

Is It Too Late To Consider HEICO (HEI) After The Recent Share Price Pullback?

Wondering if HEICO at around US$292.21 is still offering value, or if the best days are already priced in? This article focuses squarely on what you are paying versus what you might be getting. The share price sits near US$292.21 after a 4.6% decline over the past week and 12.1% over the last month, yet the stock has returned 12.1% over 1 year, 74.6% over 3 years and 140.9% over 5 years. Recent coverage has focused on HEICO as a key aerospace and defense name, with investors watching how...
NYSE:TNK
NYSE:TNKOil and Gas

Is Teekay Tankers’ (TNK) Zero‑Debt, Sanctions‑Exposed Model Reshaping Its Long‑Term Risk Profile?

Teekay Tankers recently reported strong 2025 operational and financial results, highlighting a zero‑debt balance sheet and significant free cash flow supported by a robust spot tanker market shaped by geopolitical tensions and sanctions-related trade shifts. The company’s gradual fleet renewal, focused on selective vessel acquisitions and sales while benefiting from heightened demand for compliant tankers, underscores how sanctions on Russian, Iranian, and Venezuelan oil are structurally...
NYSE:CFG
NYSE:CFGBanks

How Analyst Upgrades and San Francisco Commitments Could Reshape Citizens Financial Group’s (CFG) Investment Narrative

Earlier in March 2026, Citizens Financial Group received multiple analyst upgrades highlighting its loan growth, net interest margin expansion, and strong capital return, while simultaneously announcing new community and economic investment commitments in San Francisco, including US$250,000 for the San Francisco Downtown Development Corporation and US$500,000 for Main Street Launch. Together, these endorsements and local investments highlight Citizens’ attempt to pair national financial...
NYSE:NUVB
NYSE:NUVBPharmaceuticals

Nuvation Bio Cancer Data Update Tests Valuation Gap After Share Pullback

Nuvation Bio (NYSE:NUVB) presented nearly one additional year of follow up data from the TRUST-I and TRUST-II studies of IBTROZI (taletrectinib) at the AACR Annual Meeting 2026. The new data focus on long term efficacy and safety in ROS1 positive non small cell lung cancer, including both treatment naïve and previously treated patients. This update builds on IBTROZI's existing FDA approval and adds fresh clinical detail that has not been reflected in recent coverage of the company. Nuvation...
NYSE:CPNG
NYSE:CPNGMultiline Retail

Coupang (CPNG) Is Up 8.4% After Showcasing NVIDIA-Powered “AI Factory” At GTC 2026 – Has The Bull Case Changed?

Coupang recently highlighted its expanding AI capabilities at NVIDIA’s GTC 2026 in San Jose, detailing how its Coupang Intelligent Cloud and NVIDIA DGX SuperPOD form an “AI factory” to speed model development across its global e-commerce and logistics operations. The company is also backing NVIDIA as a launch partner for Dynamo, an open-source agentic inference software, underscoring how deeply integrated advanced AI is becoming in Coupang’s core logistics and delivery...
NYSE:KR
NYSE:KRConsumer Retailing

Cold Case Rollout Tests Kroger’s Premium Ice Cream And Brand Strategy

Cold Case Ice Cream is expanding into more than 1,000 Kroger banner stores across the US. The rollout brings a trend-focused premium ice cream brand to a wide range of Kroger owned banners. The move underscores Kroger's focus on differentiated product assortments in the grocery aisle. For investors watching NYSE:KR, this large scale rollout highlights how Kroger is using branded partnerships to keep its frozen aisle fresh and relevant. The company operates a broad network of supermarket...
NYSE:ATI
NYSE:ATIAerospace & Defense

Is ATI's Expanded US$500 Million Buyback a Clear Signal on Capital Priorities and EPS Focus?

ATI Inc. recently expanded its share repurchase program, with the board approving an additional US$500 million authorization that can be executed in the open market or through privately negotiated transactions without timing restrictions. This larger buyback pool, coming on top of prior repurchases that have already helped earnings per share grow faster than revenue, underscores management’s confidence in ATI’s long-term performance and capital return priorities. Next, we’ll examine how...
NasdaqGS:PDD
NasdaqGS:PDDMultiline Retail

PDD Holdings (PDD) Valuation Check As Options Volatility Climbs Before 2026 Earnings

PDD Holdings (PDD) is back in focus after options activity pointed to elevated implied volatility ahead of its March 25, 2026 earnings release, with investor attention also shaped by shifting ecommerce competition. See our latest analysis for PDD Holdings. Recent trading reflects this tension, with a 4.08% 1 month share price return contrasted against a 9.83% year to date share price decline and a 17.68% 1 year total shareholder return decline. This suggests momentum has been uneven as...
NasdaqGS:MU
NasdaqGS:MUSemiconductor

Is It Too Late To Consider Micron Technology (MU) After Its Surging Share Price?

For investors wondering whether Micron Technology at US$461.69 is priced for perfection or still offers value, this article walks through what the numbers indicate about the stock. The share price performance has been strong, with returns of 14.5% over 7 days, 12.2% over 30 days, 46.4% year to date, 355.4% over 1 year, around 7x over 3 years, and 454.1% over 5 years. These moves can change how investors think about both upside and risk. These moves are playing out against a backdrop where...
NYSE:GOLD
NYSE:GOLDRetail Distributors

Assessing Gold.com (GOLD) Valuation After Board Changes And New Commodities Expertise

Gold.com (GOLD) drew investor attention after appointing Juan Sartori to its Board of Directors and announcing the retirement of longtime director Beverley Lepine, a governance shift linked to experience in commodities and alternative assets. See our latest analysis for Gold.com. The Board change comes as Gold.com trades at a share price of $47.89, with a 46.45% 90 day share price return and a 71.11% 1 year total shareholder return. This suggests recent momentum has been strong despite a...
NasdaqGS:WGS
NasdaqGS:WGSHealthcare

A Look At GeneDx Holdings (WGS) Valuation After Ark Buying And Zevra Genetic Testing Partnership

GeneDx Holdings (WGS) is back in focus after Ark Invest’s ETFs bought shares for seven straight trading days, alongside a new Niemann Pick disease type C genetic testing collaboration with Zevra Therapeutics. See our latest analysis for GeneDx Holdings. Despite Ark’s buying streak and the new Zevra partnership, GeneDx’s share price has been under pressure, with a 30 day share price return of a 16.25% decline and a year to date share price return of a 42.93% decline, while the three year total...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

A Look At EyePoint Pharmaceuticals (EYPT) Valuation Following Recent Mixed Share Price Performance

Recent performance snapshot EyePoint (EYPT) has drawn attention after mixed recent returns, with the share price up about 7% over the past month but showing a decline over the past 3 months and year to date. At a last close of US$13.90 and a market value of about US$1.12b, investors are weighing this performance against the company’s focus on retinal disease treatments and its developing product pipeline. See our latest analysis for EyePoint. That mix of a 7.42% 30 day share price return...